About Us
Zhuhai Trinomab Pharmaceutical Co., Ltd. (Trinomab) is a biopharmaceutical company with a global expansion perspective. The company is mainly engaged in R&D of novel fully native human monoclonal antibody (mAb) drugs. The core technology of the company is known as the fourth-generation antibody technology HitmAb®, a proprietary technology platform featuring differentiated advantages and high efficiency for the discovery of fully native human mAbs against infectious diseases, autoimmune disorders, malignant tumors and other human diseases.
The fourth-generation antibody technology HitmAb® "High throughput fully native human mAbs R&D technology Platform"
News Center
Join Us

Trinomab therapeutics for you regardless poor or rich , in sickness or health.


Trinomab is making the transition from an early R&D biotech company to a biopharmaceutical company and eventually a global pharmaceutical

Trinomab is open to all talents having a passion for biopharmaceutical industry


To learn more jobs offered by Trinomab, you can click the link to the company's home page on the following recruitment platforms:

Trinomab at BOSS   Trinomab at www. 51job.com   Trinomab at www. liepin.com